DECISION OF THE EUROPEAN PARLIAMENT
of 21 April 2004
concerning discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002
(2004/710/EC)
RESOLUTION
of the European Parliament containing the comments accompanying the decision on the discharge to the Director of the European Agency for the Evaluation of Medicinal Products in respect of the implementation of its budget for the financial year 2002
(1000 euro) |
||
|
2002 |
2001 |
Revenue received during the financial year (5) |
|
|
Commission subsidy |
14 534 |
14 000 |
Community subsidy for orphan medicines |
2 407 |
1 300 |
Fees |
38 372 |
42 708 |
EEE contribution |
313 |
288 |
Sundry revenue |
1 750 |
4 504 |
Total revenue (a) |
57 376 |
62 800 |
Expenditure |
|
|
Staff — Title I of the budget |
|
|
Payments |
25 793 |
22 437 |
Appropriations carried over |
424 |
538 |
Administration — Title II of the budget |
|
|
Payments |
8 807 |
8 143 |
Appropriations carried over |
1 910 |
4 851 |
Operating expenditure — Title III of the budget |
|
|
Payments |
16 990 |
17 687 |
Appropriations carried over |
4 477 |
8 113 |
Total expenditure (b) |
58 401 |
61 769 |
Outturn for the financial year (a - b) (6) |
- 1 025 |
1 031 |
Balance carried over from the previous financial year |
4 040 |
1 926 |
Reimbursement to the Commission |
- 4 040 |
0 |
Sums carried over from the previous financial year and cancelled |
1 377 |
1 258 |
Exchange rate differences |
- 141 |
345 |
Other adjustments |
- 211 |
- 520 |
Balance for the financial year |
0 |
4 040 |
NB: Discrepancies in totals are due to the effects of rounding. Source: The Agency's data. These tables summarise the data provided by the Agency in its own financial statements. |